Tina C.
About Tina C.
Tina C. is the Quality Operations Compliance Manager at Bristol Myers Squibb with over a decade of experience in the pharmaceutical industry, including roles at Pfizer, Mylan, and Amgen.
Current Role at Bristol Myers Squibb
Tina C. is presently serving as the Quality Operations Compliance Manager at Bristol Myers Squibb. She assumed this role in January 2021 after transitioning from her position as a Senior Quality Operations Compliance Specialist, a role she held from 2019 to 2021. In her current capacity, she oversees compliance with quality operations, ensuring adherence to stringent industry standards and regulatory requirements. Her responsibilities likely include managing compliance activities, conducting audits, and implementing quality assurance processes.
Experience at Pfizer
Prior to her tenure at Bristol Myers Squibb, Tina C. worked at Pfizer as a Quality Officer from 2016 to 2019, a period of three years. In this role, she would have been responsible for maintaining quality management systems, ensuring product quality, and compliance with regulatory standards. This position allowed her to gain significant insights and practical experience in quality operations within a leading pharmaceutical company.
Career at Mylan
Earlier in her career, Tina C. held two positions at Mylan, a pharmaceutical company in Baldoyle. From 2014 to 2016, she worked as an Analytical Chemist for two years, where she performed chemical analyses and quality testing of pharmaceutical products. Before that, she served as a Laboratory Technician for nine months between 2013 and 2014, gaining hands-on experience in laboratory procedures and the handling of analytical instruments.
Education and Qualifications
Tina C. holds a Master of Science (MSc) in Quality Assurance & Regulation from Dublin Institute of Technology, which she completed between 2013 and 2015. Prior to this, she earned a Bachelor of Science (B.Sc.) in Pharmacology from University College Dublin, graduating in 2012 after four years of study. Her academic background provided her with a solid foundation in scientific principles and regulatory frameworks, crucial for her roles in the pharmaceutical industry.